We are live on ! Find out more
NTGN

Neon Therapeutics, Inc. Common Stock
NTGN

Delisted

NTGN was delisted on the 5th of May, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of NTGN yet.

NTGN Hedge Fund Activity: Q2 2020 in Review

0 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Neon Therapeutics, Inc. Common Stock (NTGN) for Q2 2020, worth a combined $0 — down 100% from $39.9M a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of NTGN and 0 opened new positions — a net loss of 43 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was TRV GP III, exiting entirely with an estimated $25.7M sold.

  • 0 institutional investors held Neon Therapeutics, Inc. Common Stock (NTGN) as of Q2 2020, down from 43 in Q1 2020.
  • Funds reported $0 of Neon Therapeutics, Inc. Common Stock stock for Q2 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Neon Therapeutics, Inc. Common Stock positions in Q2 2020 and 43 closed out, a net change of -43 holders.
  • The largest Neon Therapeutics, Inc. Common Stock seller in Q2 2020 was TRV GP III, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2020.